A fee-based consultancy service to developers of:
- pharmaceuticals
- biopharmaceuticals
- medical devices
- diagnostics
We work with you in the early stages of product development. Our mission is to encourage you to consider the relative clinical and cost effectiveness of your products. These considerations can then inform your development strategy.
Our advice helps you prepare for NICE evaluations and supports discussions with payers and commissioners to enable market access.
Engaging with scientific advice can:
- help you develop evidence that demonstrates the value of your product
- provide detailed feedback on your clinical, economic development and evidence generation plans
- provide insights from NICE-appointed experts
- advise on the advantages and disadvantages of different options
- help to integrate cost-effectiveness considerations into your evidence generation plans
- help companies understand health technology assessments, and the perspective of decision makers, at our educational seminars and events.
To find out more about our wide range of services, choose from one of the options below and read our frequently asked questions.
You can find out more about the team on our biographies page.
AdviSeMe prize open
- Are you a healthcare SME, academic research group or charity?
- Are you developing a transformative healthcare product for the NHS?
- Could your product improve health outcomes or save money for the NHS?
- Would you like our input on your evidence development plans?
If so, apply for the NICE Advise Me prize – win a light scientific advice service worth £15,000.
Pharmaceutical products
Standard scientific advice
Detailed advice from NICE and a panel of appointed experts.
NICE-MHRA scientific advice
Joint regulatory advice from the Medicines and Healthcare products Regulatory Agency and NICE Scientific Advice.
HTA-EMA scientific advice
Advice from the European Medicines Agency in parallel with NICE and other European Health Technology Assessment bodies.
Advice for small and medium-sized companies
A concise, more affordable version of our standard advice process.
Read our FAQs
Devices and diagnostics
Medtech Early Technical Assessment (META) tool
An affordable platform to help product developers understand what evidence is needed to make a convincing case to payers and commissioners for their technology.
Standard scientific advice
Detailed advice from NICE and a panel of appointed experts.
Advice for small and medium-sized companies
A concise, more affordable version of our standard advice process.
Read our FAQs
Seminars, events and speaking engagements
13 July 2017 - London
Advanced Workshop: for developers of devices and diagnostics
Do you:
- want to understand more about how we evaluate medical technologies and produce guidance?
- want to gain insight into factors that influence committee decision-making at NICE?
Then come along to this one-day seminar.
18 July 2017 - London
Advanced Workshop: for developers of gene and cell therapies
- Get insight into different evaluation programmes for cell or gene therapy.
- Understand relevant evaluation issues and how to prepare for them.
- Learn about services available to support you.